Koichi Miyamura Selected Research

Bone Marrow Transplantation (Transplantation, Bone Marrow)

1/2022	Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission.
1/2021	Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.
11/2020	Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia.
2/2020	Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.
1/2020	Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
1/2020	[Leukemic pulmonary infiltration diagnosed by sputum Giemsa-staining].
12/2019	High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.
1/2019	Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.
1/2018	Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation.
7/2017	Toll-like receptor genetic variations in bone marrow transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Miyamura Research Topics

Disease

29	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 09/2004
22	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 11/2005
18	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2006
18	Leukemia 11/2020 - 09/2004
16	Philadelphia Chromosome 01/2022 - 09/2004
15	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 12/2005
12	Infections 12/2021 - 04/2004
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 02/2009
9	Neoplasms (Cancer) 07/2020 - 09/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 03/2012
6	Bronchiolitis Obliterans Syndrome 12/2019 - 11/2007
6	Aplastic Anemia (Anemia, Hypoplastic) 08/2019 - 01/2008
4	Hematologic Diseases (Blood Diseases) 06/2022 - 10/2003
4	Residual Neoplasm 11/2017 - 08/2006
3	Febrile Neutropenia 06/2022 - 08/2012
3	Lymphoma (Lymphomas) 01/2011 - 03/2002
2	COVID-19 10/2022 - 01/2021
2	Bacteremia 06/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2021 - 10/2006
2	Iron Overload 01/2015 - 01/2013
2	Diarrhea 01/2012 - 05/2006
2	Autoimmune Diseases (Autoimmune Disease) 01/2011 - 11/2007
1	Muscle Weakness 08/2022
1	Neurolymphomatosis 08/2022
1	Adenoviridae Infections (Adenovirus Infections) 12/2020
1	Virus Diseases (Viral Diseases) 12/2020
1	Malnutrition (Nutritional Deficiencies) 11/2019
1	Esophageal Neoplasms (Esophageal Cancer) 10/2018
1	Splenomegaly 02/2018
1	Polycythemia Vera 02/2018
1	Pruritus (Itching) 02/2018
1	Disease Progression 11/2017
1	Chemotherapy-Induced Febrile Neutropenia 01/2017
1	Inflammation (Inflammations) 01/2017
1	Dysbiosis 01/2017

Drug/Important Bio-Agent (IBA)

13	Imatinib Mesylate (Gleevec)FDA Link 12/2019 - 09/2004
6	Tacrolimus (Prograf)FDA LinkGeneric 10/2020 - 05/2006
6	HLA Antigens (Human Leukocyte Antigens)IBA 02/2020 - 11/2010
6	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 05/2006
6	Tyrosine Kinase InhibitorsIBA 12/2017 - 04/2012
6	nilotinib FDA Link 11/2017 - 06/2009
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 10/2003
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 05/2006
5	AntigensIBA 03/2016 - 03/2002
4	SteroidsIBA 09/2018 - 04/2012
4	HLA-A Antigens (HLA-A)IBA 03/2016 - 03/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2015 - 04/2004
3	Rituximab (Mabthera)FDA Link 09/2021 - 10/2006
3	fludarabineIBA 05/2006 - 04/2004
2	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 01/2017
2	bosutinibIBA 09/2017 - 01/2015
2	Toll-Like Receptor 1IBA 07/2017 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	ThrombomodulinIBA 10/2015 - 10/2015
2	IronIBA 01/2015 - 01/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014 - 04/2012
2	PalmitatesIBA 01/2014 - 04/2012
2	HLA-DR Antigens (HLA-DR)IBA 03/2012 - 02/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2010 - 09/2009
2	Monoclonal AntibodiesIBA 09/2009 - 02/2007
2	EnzymesIBA 11/2007 - 05/2006
1	GadoliniumIBA 08/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 06/2022
1	beta-Lactamases (beta-Lactamase)IBA 06/2022
1	Cefepime (Maxipime)FDA LinkGeneric 06/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	Cidofovir (Vistide)FDA Link 12/2020
1	Foscarnet FDA LinkGeneric 12/2020
1	Transcription Factors (Transcription Factor)IBA 07/2020
1	eltrombopag FDA Link 08/2019
1	Thrombopoietin ReceptorsIBA 08/2019
1	IodineIBA 10/2018
1	ruxolitinibIBA 02/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Toll-Like Receptor 4IBA 07/2017
1	Toll-Like Receptor 2IBA 07/2017
1	Biological ProductsIBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	ponatinibIBA 01/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Pancreatitis-Associated ProteinsIBA 01/2017

Therapy/Procedure

33	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 02/2007
31	Hematopoietic Stem Cell Transplantation 12/2021 - 09/2003
26	Transplantation 10/2022 - 04/2004
20	Therapeutics 06/2022 - 12/2005
16	Stem Cell Transplantation 06/2017 - 02/2004
13	Cell Transplantation 12/2019 - 02/2009
7	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2022 - 11/2005
7	Drug Therapy (Chemotherapy) 08/2022 - 05/2009
2	Homologous Transplantation 01/2006 - 11/2005
1	Blood Component Removal (Apheresis) 10/2022
1	Catheters 01/2021
1	Photopheresis 09/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Induction Chemotherapy 01/2018